| Trial name or title | Smoking cessation study in healthy adolescent smokers |
| Methods | Phase IV randomised triple‐blind placebo‐controlled trial |
| Participants | 300 healthy adolescents (12 ‐ 19 yrs) smoking at least 5 CPD, with at least 1 failed quit attempt |
| Interventions | Varenicline 1 mg x 2/day vs varenicline 0.5 mg x 2/day vs placebo |
| Outcomes | CAR at weeks 9 ‐ 12, 9 ‐ 24, 9 ‐ 52; 7‐day PPA at wks 12, 24, 52; CPD reduction |
| Starting date | April 2011 |
| Contact information | Pfizer Inc |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.